Dr. Elizabeth (Liz) Newman focuses her work on patent drafting and assisting prosecution. She also has experience in IP due diligence inquiries, including freedom-to-operate analyses, with an emphasis on biotechnology and pharmaceuticals.

Liz has worked with a wide range of clients, including startup biotech companies, large pharmaceutical companies, and universities. She has worked with clients in a number of areas, primarily in cancer immunotherapy.

Liz received her Ph.D., dissertation awarded with honors, in microbiology and immunology from New York Medical College, where she studied antibody responses to influenza and concentrated on viral genomics, vaccine design, high throughput immunological assays including epitope mapping, molecular biology, and confocal microscopy.

She received her B.S. in molecular and cellular biology from Mills College in Oakland, California.